BiotechTube
AJ Vaccines

AJ Vaccines

Copenhagen, Denmark· Est.
ajvaccines.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $50M

Overview

AJ Vaccines is a private, revenue-generating company founded in 2014 (operationally established in 2017) from the divestment of vaccine production at Denmark's Statens Serum Institut. It combines deep historical expertise in vaccine manufacturing with a modern, global outlook, employing over 500 people. Its core business involves the commercial production of vaccines, notably for polio, and the development of innovative solutions like dose-sparing technologies. The company is a key supplier to childhood vaccination programs and the WHO's Global Polio Eradication Initiative.

Infectious Diseases

Technology Platform

Established large-scale manufacturing for inactivated vaccines, with a focus on innovative dose-sparing technology for polio vaccine to expand global supply.

Funding History

1
Total raised:$50M
Debt$50M

Opportunities

The global push for polio eradication creates sustained demand for IPV, particularly cost-effective, dose-sparing formulations.
Additionally, the post-pandemic focus on European vaccine manufacturing sovereignty presents strategic opportunities for contract development and manufacturing (CDMO) services or new vaccine production.

Risk Factors

Key risks include revenue concentration in polio vaccines, creating vulnerability to eradication progress or procurement changes, and a lack of publicly disclosed diversified pipeline, which could limit long-term growth.
Operational risks include supply chain dependencies and concentrated manufacturing in one site.

Competitive Landscape

AJ Vaccines competes with large multinational vaccine producers (e.g., Sanofi, GSK, Pfizer) and specialized players like Serum Institute of India in the polio and routine immunization market. Its differentiation lies in its specific dose-sparing IPV technology, its heritage of Danish quality, and its role as a dedicated, mid-sized European manufacturer.

More companies in Biologics / Biosimilars →More companies in Denmark →